Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Science
    July 2022
  1. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    >> Share

  2. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    >> Share

  3. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    >> Share

  4. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    >> Share

    January 2022
  5. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    >> Share

    December 2021
  6. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    >> Share

    October 2021
  7. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    >> Share

  8. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    >> Share

  9. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    >> Share

    August 2021
  10. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    >> Share

  11. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    >> Share

    July 2021
  12. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    >> Share

    June 2021
  13. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    >> Share

    December 2020
  14. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    >> Share

    November 2020
  15. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    >> Share

    October 2020
  16. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    >> Share

  17. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    >> Share

  18. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    >> Share

    August 2020
  19. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    >> Share

    December 2019
  20. SERVICK K
    Doubts persist for claimed Alzheimer's drug.
    Science. 2019;366:1298.
    >> Share

    November 2019
  21. SERVICK K
    Rare case offers clues to staving off Alzheimer's.
    Science. 2019;366:674.
    >> Share

    August 2019
  22. ZOTT B, Simon MM, Hong W, Unger F, et al
    A vicious cycle of beta amyloid-dependent neuronal hyperactivation.
    Science. 2019;365:559-565.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016